These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 28539285

  • 1. [Diagnostic value of CA125, HE4 and Copenhagen Index in differentiating benign from malignant epithelial ovarian tumors].
    Gong SP, Chen YN, Zhang YD, Yao W, Chen L, Liu SS, Wu H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May 20; 37(5):628-632. PubMed ID: 28539285
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages.
    Wang Z, Tao X, Ying C.
    Dis Markers; 2019 May 20; 2019():6241743. PubMed ID: 31737130
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
    Suri A, Perumal V, Ammalli P, Suryan V, Bansal SK.
    Sci Rep; 2021 Aug 27; 11(1):17308. PubMed ID: 34453074
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X, Zhang H, Cong H, Wang X, Ni H, Shen X, Ju S.
    Pathol Oncol Res; 2018 Oct 27; 24(4):739-744. PubMed ID: 29520570
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
    Li F, Tie R, Chang K, Wang F, Deng S, Lu W, Yu L, Chen M.
    BMC Cancer; 2012 Jun 19; 12():258. PubMed ID: 22712526
    [Abstract] [Full Text] [Related]

  • 13. Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses.
    Fawzy A, Mohamed MR, Ali MA, Abd El-Magied MH, Helal AM.
    Asian Pac J Cancer Prev; 2016 Jun 19; 17(1):323-33. PubMed ID: 26838232
    [Abstract] [Full Text] [Related]

  • 14. Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
    Bandiera E, Romani C, Specchia C, Zanotti L, Galli C, Ruggeri G, Tognon G, Bignotti E, Tassi RA, Odicino F, Caimi L, Sartori E, Santin AD, Pecorelli S, Ravaggi A.
    Cancer Epidemiol Biomarkers Prev; 2011 Dec 19; 20(12):2496-506. PubMed ID: 22028406
    [Abstract] [Full Text] [Related]

  • 15. Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal women.
    Zhang P, Wang C, Cheng L, Zhang P, Guo L, Liu W, Zhang Z, Huang Y, Ou Q, Wen X, Tian Y.
    Tumour Biol; 2016 Feb 19; 37(2):2183-91. PubMed ID: 26349751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
    Ahmed AA, Abdou AM.
    Curr Probl Cancer; 2019 Oct 19; 43(5):450-460. PubMed ID: 30670303
    [Abstract] [Full Text] [Related]

  • 20. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age.
    Kondalsamy-Chennakesavan S, Hackethal A, Bowtell D, Australian Ovarian Cancer Study Group, Obermair A.
    Gynecol Oncol; 2013 Jun 19; 129(3):467-71. PubMed ID: 23500084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.